Original Webinar Date: 03/25/2025

The RNA advantage: A multimodal approach to accelerating oncology R&D

Discover how transcriptomic data and multi-omics data integrated with AI is helping revolutionize oncology drug development and patient care and fueling precision medicine 2.0. Learn about RNA sequencing’s role in companion diagnostics and Tempus Loop’s capabilities to support target identification and validation.
Speakers Internal:
Justin Guinney, PhD
SVP of Cancer Genomics, Tempus


External:
Rafael Rosengarten, PhD
CEO & Co-founder, Genialis


Sadnip Patel, MD
Professor of Medical Oncology, UC San Diego

Related Content

View more
  • post image
    08/29/2025

    Precision Medicine 2.0: The operating system for oncology R&D

    This white paper addresses the persistent challenges in oncology R&D, demonstrating how precision medicine has evolved into a new paradigm built on systems-level understanding and AI-driven insights. Download for a comprehensive overview of Precision Medicine 2.0, its core scientific pillars, enabling technologies, and how R&D organizations can leverage this integrated approach to optimize their cancer research.

    Read more
  • post image
    08/15/2025

    Tempus’ data solutions for commercialization

    Learn how our multimodal real-world data can help quantify new market opportunities, build your value story, and inform your market access strategy.

    Read more
  • post image
    08/15/2025

    Tempus’ data solutions for clinical development

    Learn how our multimodal real-world data can help you optimize trial design, mitigate risk, and inform your companion diagnostic strategy.

    Read more